1. Home
  2. LXEO vs WEA Comparison

LXEO vs WEA Comparison

Compare LXEO & WEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • WEA
  • Stock Information
  • Founded
  • LXEO 2017
  • WEA 2002
  • Country
  • LXEO United States
  • WEA United States
  • Employees
  • LXEO 72
  • WEA N/A
  • Industry
  • LXEO
  • WEA Trusts Except Educational Religious and Charitable
  • Sector
  • LXEO
  • WEA Finance
  • Exchange
  • LXEO Nasdaq
  • WEA Nasdaq
  • Market Cap
  • LXEO 154.0M
  • WEA 129.0M
  • IPO Year
  • LXEO 2023
  • WEA N/A
  • Fundamental
  • Price
  • LXEO $2.69
  • WEA $10.61
  • Analyst Decision
  • LXEO Strong Buy
  • WEA
  • Analyst Count
  • LXEO 5
  • WEA 0
  • Target Price
  • LXEO $22.20
  • WEA N/A
  • AVG Volume (30 Days)
  • LXEO 892.8K
  • WEA 46.1K
  • Earning Date
  • LXEO 05-20-2025
  • WEA 01-01-0001
  • Dividend Yield
  • LXEO N/A
  • WEA 7.87%
  • EPS Growth
  • LXEO N/A
  • WEA N/A
  • EPS
  • LXEO N/A
  • WEA N/A
  • Revenue
  • LXEO N/A
  • WEA N/A
  • Revenue This Year
  • LXEO N/A
  • WEA N/A
  • Revenue Next Year
  • LXEO N/A
  • WEA N/A
  • P/E Ratio
  • LXEO N/A
  • WEA N/A
  • Revenue Growth
  • LXEO N/A
  • WEA N/A
  • 52 Week Low
  • LXEO $1.45
  • WEA $9.60
  • 52 Week High
  • LXEO $19.50
  • WEA $11.29
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 41.96
  • WEA 44.92
  • Support Level
  • LXEO $2.77
  • WEA $10.56
  • Resistance Level
  • LXEO $3.35
  • WEA $10.72
  • Average True Range (ATR)
  • LXEO 0.62
  • WEA 0.16
  • MACD
  • LXEO -0.09
  • WEA -0.02
  • Stochastic Oscillator
  • LXEO 0.69
  • WEA 15.22

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

About WEA Western Asset Bond Fund Share of Beneficial Interest

Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.

Share on Social Networks: